Huibang Biotech was recognized as a new research and development institution in Anhui Province

Date：

2022-02-16

Recently, the Anhui Provincial Department of Science and Technology officially announced the list of newly recognized new research and development institutions in Anhui Province in 2021, and Anhui Huibang Bioengineering Co., Ltd. (hereinafter referred to as Huibang Biology) ranked third. 

Anhui Province's new R&D institutions are mainly oriented to the key areas of strategic emerging industry cluster development and traditional industry transformation and upgrading. They gather high-quality innovation elements, break through key common technologies in industries, serve technological innovation of enterprises, and support industrial transformation and upgrading. They are a gathering platform for innovation and entrepreneurship resources. , a gathering platform for high-end talent teams, an integration platform for advanced industrial technologies, and a test platform for scientific and technological system reform are important components of Anhui's scientific and technological innovation system.

Huibang Biotechnology is a national high-tech enterprise integrating R&D, production and sales. Over the years, the company has attached great importance to technological innovation and research and development, and successfully developed monoclonal antibody raw materials, liquid phase chemiluminescence technology, molecular diagnostic precision medical technology, blood screening technology, fluorescent immunological POCT technology, rapid immunoassay technology, dry chemical rapid detection technology, Tumor cell drug sensitivity test detection technology, in vitro diagnostic automatic equipment development technology (optical sensing development technology, mechanical transmission development technology, integrated circuit control module development technology, automation control development technology, software development), etc., have obtained more than 50 intellectual property patents items, including 17 invention patents.

Coincidentally, Huibang's research and development of biological raw materials and liquid phase chemiluminescence innovative technology have been included in the key areas of the "Hefei "14th Five-Year" Biomedical Industry Development Plan", fully affirming the correct development direction of the company's innovative technology products.

In the future, the company will continue to increase scientific research cooperation and scientific research and development investment with University of Science and Technology of China, Anhui Medical University, Anhui University of Traditional Chinese Medicine, and Capital Medical University, and accelerate the transformation and application of scientific and technological achievements. Seize development opportunities and strive to build the company into a world-class high-tech biomedical company!

Related News

2024-01-22

Serving the big health industry, leapfrogging development of industry, academia and research - Anhui Huibang Biotech bloomed at the Anhui Traditional Chinese Medicine Academic Annual Conference

2023-08-07

Urine and nephropathy and defense -Dialogue column of the Diabetes Branch of the Chinese Medical Association

On August 4, 2023, the Chinese Medical Association Diabetes Branch 2023 Education Management Academic Conference was grandly held at Fengda International Hotel, Hefei City, Anhui Province.

2023-06-29

Good news! Huibang Biotechnology won the second prize of Science and Technology Progress Award of the Ministry of Education!

Recently, the Ministry of Education issued a certificate for the Outstanding Achievement Award (Science and Technology) of Scientific Research in Institutions of Higher Learning. Anhui Huibang Bioengineering Co., Ltd. jointly with the Chinese Academy of Sciences and Capital Medical University declared the project: "Research and Application of Molecular Targets for Diabetes" won the second prize of Science and Technology Progress Award of the Ministry of Education.

2023-06-12

Huibang Biotech actively implements the Hangzhou Declaration and contributes to building a healthy China

On June 11, 2023, the first China Health Promotion Conference was successfully held in Hangzhou. The conference was high-level and large-scale, and many guests from the government, medical and health circles, sports circles, education circles, science and technology circles, mass media, NGO organizations and business circles attended.

2023-06-01

Good news! Huibang Biotechnology won the "Star of Creation" Cup Innovative Product Gold Award

Wisdom medicine is upright and innovative | "Star of Creation" The 8th China Experimental Medicine Conference was grandly opened on May 27 at the Primus Hotel Conference Center in Nanchang! Huibang Bio's innovative product insulin-like growth factor binding protein-1/fetal fiber Connexin (IGFBP-1/fFN) detection kit won the 2022 "Innovation Star" Cup China Excellent Innovative Product Gold Award for In Vitro Diagnostics.